ArticleJournal of travel medicine2023
Bivalent mRNA-1273.214 vaccine effectiveness against SARS-CoV-2 omicron XBB* infections.
Abstract read
In one paragraph
Article in Journal of travel medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Two Versus One COVID-19 Vaccine Dose After Prior SARS-CoV-2 Infection: A Nationwide Retrospective Cohort Study.Open forum infectious diseases · 2026Article
- Tracking the shifting landscape of SARS-CoV-2 variants in Lebanon among healthcare workers and hospitalized patients.Microbiology spectrum · 2026Article
- Risk of stroke following SARS-CoV-2 infection in a nationwide self-controlled case series study in qatar.Scientific reports · 2026Observational
- Global Estimates of COVID-19 Morbidity and Mortality: A Cohort Study and Mathematical Model Analysis.Influenza and other respiratory viruses · 2025Article
- Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in Qatar.Scientific reports · 2025Article
- Immune histories and natural infection protection during the omicron era.Communications medicine · 2025Article
- Article
- Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United States.The Journal of infectious diseases · 2025Article
- Protection conferred by SARS-CoV-2 infection across a spectrum of reinfection symptoms and severities.BMJ open respiratory research · 2025Article
- Evaluating Hospital Admission Data as Indicators of COVID-19 Severity: A National Assessment in Qatar.Open forum infectious diseases · 2025Article
- Article
- Article
- Safety and antibody responses of Omicron BA.4/5 bivalent booster vaccine among hybrid immunity with diverse vaccination histories: A cohort study.Vaccine: X · 2024Article
- BNT162b2 Versus mRNA-1273 Vaccines: Comparative Analysis of Long-Term Protection Against SARS-CoV-2 Infection and Severe COVID-19 in Qatar.Influenza and other respiratory viruses · 2024Article
- Article
- Article
- Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation.Frontiers in medicine · 2024Article
- Turning point in COVID-19 severity and fatality during the pandemic: a national cohort study in Qatar.BMJ public health · 2023Article
- SARS-CoV-2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study.Influenza and other respiratory viruses · 2023Article
- The Effectiveness of Bivalent COVID-19 Vaccination: A Preliminary Report.Life (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Hiam ChemaitellyInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, PO Box 24144, Doha, Qatar.
Houssein H AyoubDepartments of Mathematics, Statistics, and Physics, and of Biomedical Science, and of Public Health, Qatar University, PO Box 2713, Doha, Qatar.
Sawsan AlMukdadInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, PO Box 24144, Doha, Qatar.
Jeremy S FaustDepartment of Emergency Medicine, Brigham and Women's Hospital, MA 02115, Boston, Massachusetts, USA.
Patrick TangDepartment of Pathology, Sidra Medicine, PO Box 26999, Doha.
Peter CoyleHamad Medical Corporation, POBox 3050, Doha, Qatar.
Hadi M YassineDepartments of Mathematics, Statistics, and Physics, and of Biomedical Science, and of Public Health, Qatar University, PO Box 2713, Doha, Qatar.
Asmaa A Al ThaniDepartments of Mathematics, Statistics, and Physics, and of Biomedical Science, and of Public Health, Qatar University, PO Box 2713, Doha, Qatar.
Hebah A Al-KhatibDepartments of Mathematics, Statistics, and Physics, and of Biomedical Science, and of Public Health, Qatar University, PO Box 2713, Doha, Qatar.
Mohammad R HasanDepartment of Pathology, Sidra Medicine, PO Box 26999, Doha.
Zaina Al-KanaaniHamad Medical Corporation, POBox 3050, Doha, Qatar.
Einas Al-KuwariHamad Medical Corporation, POBox 3050, Doha, Qatar.
Andrew JeremijenkoHamad Medical Corporation, POBox 3050, Doha, Qatar.
Anvar H KaleeckalHamad Medical Corporation, POBox 3050, Doha, Qatar.
Ali N LatifHamad Medical Corporation, POBox 3050, Doha, Qatar.
Riyazuddin M ShaikHamad Medical Corporation, POBox 3050, Doha, Qatar.
Hanan F Abdul-RahimDepartments of Mathematics, Statistics, and Physics, and of Biomedical Science, and of Public Health, Qatar University, PO Box 2713, Doha, Qatar.
Gheyath K NasrallahDepartments of Mathematics, Statistics, and Physics, and of Biomedical Science, and of Public Health, Qatar University, PO Box 2713, Doha, Qatar.ORCID 0000-0001-9252-1038
Mohamed G Al-KuwariPrimary Health Care Corporation, PO Box 26555, Doha, Qatar.
Adeel A ButtHamad Medical Corporation, POBox 3050, Doha, Qatar.ORCID 0000-0002-1118-1826
Hamad E Al-RomaihiMinistry of Public Health, PO Box 7744, doha, Qatar.
Mohamed H Al-ThaniMinistry of Public Health, PO Box 7744, doha, Qatar.
Abdullatif Al-KhalHamad Medical Corporation, POBox 3050, Doha, Qatar.
Roberto BertolliniMinistry of Public Health, PO Box 7744, doha, Qatar.
Laith J Abu-RaddadInfectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, PO Box 24144, Doha, Qatar.ORCID 0000-0003-0790-0506
Funding
Biomedical Research Program and the Biostatistics, Epidemiology, and Biomathematics Research CoreHamad Medical CorporationMinistry of Public HealthPrimary Health Care CorporationSidra Medicine and Weill Cornell Medicine
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19COVID-19 VaccinesHumansmRNA VaccinesSARS-CoV-2Vaccine EfficacyCOVID-19 VaccinesmRNA-1273.214 COVID-19 vaccinemRNA Vaccinesasymptomatic infectionHybrid immunitynatural infectionQatarvariant-containing COVID-19 vaccineswaning vaccine effectiveness
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.